The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

We came across a bearish thesis on DocuSign, Inc. (DOCU) on Deep Value Returns’ Substack. In this article, we will summarize ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

That said, Docusign stock sells for an unchallenging valuation of only 16.6 times trailing FCF -- cheaper than that when you factor in net cash on the balance sheet. If Docusign can just find a way to ...

Never mind the tariffs and tantrums. The 'dual equity pain trade' means new highs for stocks. Big investors find themselves underweight Big Tech as leadership narrows again, says JPMorgan The spat ...

DocuSign Inc. reported strong first-quarter of fiscal 2026 results while unveiling an artificial intelligence strategy.

DocuSign trimmed its full-year outlook for billing, after the closely-watched metric fell short of its guidance in the first quarter. The San Francisco e-signature company on Thursday posted a profit ...

Docusign DOCU will report first-quarter fiscal 2026 results on June 5, after market close. The Zacks Consensus Estimate for ...

FDG offers a concentrated, high-growth portfolio with mega-cap tech, consumer discretionary, and healthcare overweights, but ...

This edition of Market Factors includes a thematic investing approach uncovering stocks that outperform. New stresses in the ...

A potentially watershed effort to launch US crypto exchange-traded funds that offer staking rewards is throwing up regulatory doubts, even after the funds said they received initial SEC ...